Optimizing remotely delivered Smoking Cessation Services for Low-Income Smokers
优化为低收入吸烟者提供的远程戒烟服务
基本信息
- 批准号:10215249
- 负责人:
- 金额:$ 56.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressBiochemicalCessation of lifeCombined Modality TherapyComplementCounselingDissemination and ImplementationEffectivenessEffectiveness of InterventionsEngineeringEnrollmentEvidence based interventionHuman ResourcesIncentivesIncomeIndividualInterventionIntervention StudiesLogisticsLow Income PopulationLow incomeMalignant NeoplasmsMalignant neoplasm of lungMediator of activation proteinMedicaidOutcomePF4 GeneParticipantPatient Self-ReportPatternPharmaceutical PreparationsPoliciesPopulationPrevalencePreventable cancer causePriceRandomizedRelapseReportingResearchResourcesRewardsServicesSmokeSmokerSmokingSmoking Cessation InterventionSmoking HistorySystemTarget PopulationsTelephoneTestingTextText MessagingTimeTobaccoTobacco Use CessationTobacco useTranslatingUninsuredUnited StatesUrsidae FamilyWisconsinWorkburden of illnesscigarette smokingcomparison interventioncostcost effectivecost effectivenesscost-effectiveness evaluationdesigndigitaldisparity reductionevidence baseexperimental studyfallsfinancial incentiveflexibilityfollow up assessmentfollow-uphigh risk populationimprovedintervention effectnicotine patchnicotine replacementpreservationpreventprimary outcomeprogramsquality assurancequitlinerecruitreduce tobacco useremote deliveryresponsesmoking cessationsmoking interventionsmoking prevalencesmoking relapsesocioeconomic disadvantagesocioeconomic disparitysocioeconomicssuccesstobacco-freetreatment effecttreatment responsetreatment services
项目摘要
ABSTRACT
Cigarette smoking is the leading preventable cause of cancer and many other deadly diseases, and the burden
of tobacco use is greatest among those with limited socioeconomic resources. Although we have driven down
population smoking rates, and with them, cancer rates, roughly 28% of the socioeconomically disadvantaged
still smoke regularly. Low-income (L-I) smokers also develop cancer at higher rates and struggle more to quit
than do higher-income smokers. These disparities in tobacco use and its burdens must be addressed. Highly
effective cessation treatment services that can be delivered remotely, flexibly, and conveniently with few cost
or logistical barriers have the potential to achieve this aim. Tobacco quitline and SmokefreeTXT services are
such treatment resources with demonstrated attractiveness and reach among L-I smokers. The current
proposal will use an efficient factorial design to evaluate 4 smoking cessation interventions with vast reach and
dissemination potential. The target population will be N=1,408 Medicaid-eligible or uninsured smokers who
have recently enrolled in the Wisconsin Tobacco Quit Line (WTQL), but who report continued smoking 4-
months following engagement in standard WTQL services. These treatment non-responders will be invited to
participate in an experiment that will randomize them to 1 of 2 levels of each of the following 4 factors in a
2X2X2X2 design: WTQL counseling intensity (1 session vs. 4 sessions), medication intensity (2-week nicotine
patch monotherapy vs. 4-week nicotine patch and lozenge combination therapy), a supportive text messaging
program (SmokefreeTXT vs. none), and financial incentives (rewards of up to $150 for treatment engagement
vs. no treatment incentives). The primary outcome will be 26-week biochemically confirmed point-prevalence
abstinence. Analyses will examine the main and interactive effects of these 4 treatment components on 26-
week and secondary abstinence outcomes to identify the components and combinations of components that
significantly enhance success in quitting in this high-risk population. This experiment will identify especially
effective combinations of highly scalable interventions of modest cost and few barriers that could be
disseminated nationally to reduce socioeconomic disparities in smoking cessation among those seeking to
quit. Additional analyses will: compare intervention components and promising component combinations in
terms of cost-effectiveness, examine whether or not treatment engagement differs across component
combinations, examine baseline variables that may moderate treatment response, and identify mediators of
treatment effects on abstinence outcomes. Because delivery of the study interventions can be centralized
through established and efficient services (WTQL and SmokefreeTXT), the potential for both scalable
dissemination and cost-effectiveness of the interventions tested is great. The proposed research will help
identify ways to reduce tobacco cessation disparities in L-I smokers who have tried to quit smoking but
relapsed and may benefit from improved assistance.
摘要
吸烟是癌症和许多其他致命疾病的主要可预防原因,也是
在社会经济资源有限的人群中,烟草使用率最高。尽管我们已经开到了
人口吸烟率,以及随之而来的癌症发病率,大约28%的社会经济弱势群体
仍然经常吸烟。低收入(L-I)吸烟者患癌症的几率也更高,戒烟的难度更大
比高收入的吸烟者更多。必须解决烟草使用及其负担方面的这些差异。高度
有效的戒烟治疗服务,可远程、灵活、方便地提供,且成本较低
或者,后勤障碍有可能实现这一目标。烟草戒烟热线和免费吸烟TXT服务是
这些治疗资源在L-I吸烟者中具有吸引力和覆盖面。海流
提案将使用有效的析因设计来评估覆盖范围广泛的4种戒烟干预措施
传播潜力。目标人群将是N=1,408名符合医疗补助资格或未参保的吸烟者
最近加入了威斯康星州戒烟热线(WTQL),但报告继续吸烟的人有4-
在参与标准WTQL服务几个月后。这些治疗无效的人将被邀请到
参与一项实验,将他们随机分成以下4个因素中每个因素的2个水平之一
2X2X2X2设计:WTQL咨询强度(1次与4次),用药强度(2周尼古丁
贴片单一疗法与四周尼古丁贴片和含片联合疗法),支持性短信
计划(免费TXT与无)和经济奖励(参与治疗最高可获得150美元奖励)
与没有治疗激励措施相比)。主要结果将是生化确诊的26周点流行率。
禁欲。分析将考察这4个治疗成分对26-
一周和二次戒断结果,以确定以下成分及其组合
在这一高危人群中显著提高戒烟成功率。这项实验将特别地识别
成本适中、障碍少、高度可扩展的干预措施的有效组合
在全国范围内传播,以减少寻求戒烟的人在社会经济方面的差距
不干了。其他分析将:比较干预组件和有希望的组件组合
在成本效益方面,检查不同组件的治疗参与度是否不同
组合,检查可能缓和治疗反应的基线变量,并确定
治疗对禁欲结果的影响。因为研究干预措施的交付可以集中进行
通过建立和高效的服务(WTQL和SmokeFree TXT),两者的潜力都是可扩展的
所测试的干预措施的传播和成本效益都很高。拟议中的研究将有所帮助
找出减少L吸烟者戒烟差距的方法--吸烟者曾试图戒烟但
复发,并可能受益于更好的援助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL C FIORE其他文献
MICHAEL C FIORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL C FIORE', 18)}}的其他基金
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
改变医疗保健中烟草使用的治疗:抓住电子健康记录的潜力,提供全面的吸烟慢性病护理治疗
- 批准号:
9316570 - 财政年份:2015
- 资助金额:
$ 56.89万 - 项目类别:
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
改变医疗保健中烟草使用的治疗:抓住电子健康记录的潜力,提供全面的吸烟慢性病护理治疗
- 批准号:
10005034 - 财政年份:2015
- 资助金额:
$ 56.89万 - 项目类别:
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
改变医疗保健中烟草使用的治疗:抓住电子健康记录的潜力,提供全面的吸烟慢性病护理治疗
- 批准号:
10411423 - 财政年份:2015
- 资助金额:
$ 56.89万 - 项目类别:
Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care
利用国家癌症研究所的癌症中心戒烟倡议 (C3I) 计划来评估和转变癌症护理中的戒烟治疗
- 批准号:
10707958 - 财政年份:2015
- 资助金额:
$ 56.89万 - 项目类别:
Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care
利用国家癌症研究所的癌症中心戒烟倡议 (C3I) 计划来评估和转变癌症护理中的戒烟治疗
- 批准号:
10517948 - 财政年份:2015
- 资助金额:
$ 56.89万 - 项目类别:
Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking
评估基于 EHR 的卫生系统改革对吸烟慢性病护理的影响
- 批准号:
8655740 - 财政年份:2014
- 资助金额:
$ 56.89万 - 项目类别:
Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach
优化吸烟者长期护理:比较有效性方法
- 批准号:
9335278 - 财政年份:2014
- 资助金额:
$ 56.89万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 56.89万 - 项目类别:
Research Grant














{{item.name}}会员




